The effects of L-arginine on neurological function, histopathology, and expression of hypoxia-inducible factor-1 alpha following spinal cord ischemia in rats

European Surgical Research

Volumn 37, Issue 6, 2005, Pages 323-329

  Cudi Tuncer, M ^a   Savas Hatipoglu, E ^a   Ozturk, H ^a   Kervancioglu, P ^a   Buyukbayram, H ^a  

^a DICLE UNIVERSITY   (Turkey)

Author keywords

Hypoxia inducible factor 1 ; Ischemia and reperfusion injury; L Arginine; Spinal cord

Indexed keywords

ARGININE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MALONALDEHYDE; NITRIC OXIDE DONOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA OCCLUSION; ARTICLE; BLOOD GAS; CELL PROLIFERATION; CONTROLLED STUDY; GRAY MATTER; HISTOPATHOLOGY; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; ISCHEMIA; MALE; MEAN ARTERIAL PRESSURE; MICROGLIA; MOTONEURON; NONHUMAN; PARAPLEGIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SPINAL CORD; SPINAL CORD ISCHEMIA; TEMPERATURE; UPREGULATION;

ANIMALS; ARGININE; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; MALE; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR; REPERFUSION INJURY; SPINAL CORD ISCHEMIA; UP-REGULATION;

EID: 32244434410     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000090331     Document Type: Article

References (43)

1. Lee JC, Hwang IK, Yoo KY, Jung JY, Cho JH, Moon SM, Kang TC, Kim WK, Kim YS, Won MH: Calbindin D-28k is expressed in the microvascular basal lamina in the ventral horn at early time after transient spinal cord ischemia in the rabbit. Brain Res 2005;1047:123-128.
2. Gelman S, Reves JG, Fowler K, Samuelson PN, Lell WA, Smith LR: Regional blood flow during cross-clamping of the thoracic aorta and infusion of sodium nitroprusside. J Thorac Cardiovasc Surg 1983;85:287-291.
3. Gelman S: The pathophysiology of aortic cross-clamping and unclamping. Anesthesiology 1995;82:1026-1060.
4. Cox GS, O'Hara PJ, Hertzer NR, Piedmonte MR, Krajewski LP, Beven EG: Thoracoabdominal aneurysm repair: a representative experience. J Vasc Surg 1992;15:780-787.
5. Verdant A, Cossette R, Page A, Baillot R, Dontigny L, Page P: Aneurysms of the descending thoracic aorta: three hundred sixty-six consecutive cases resected without paraplegia. J Vasc Surg 1995;21:385-390.
6. Lang-Lazdunski L, Heurteaux C, Vaillant N, Widmann C, Lazdunski M: Riluzole prevents ischemic spinal cord injury caused by aortic crossclamping. J Thorac Cardiovasc Surg 1999;117:881-889.
7. Lang-Lazdunski L, Bachet J: Pharmacological spinal cord protection with magnesium during replacement of the thoracic and thoracoabdominal aorta. Ann Thorac Surg 2001;72:2180-2181.
8. Wang GL, Semenza GL: Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 1995;270:1230-1237.
9. Zhang B, Tanaka J, Yang L, Yang L, Sakanaka M, Hata R, Maeda N, Mitsuda N: Protective effect of vitamin E against focal brain ischemia and neuronal death through induction of target genes of hypoxia-inducible factor-1. Neuroscience 2004;126:433-440.
10. Liu Y, Christou H, Morita T, Laughner E, Semenza GL, Kourembanas S: Carbon monoxide and nitric oxide suppress the hypoxic induction of vascular endothelial growth factor gene via the 5′ enhancer. J Biol Chem 1998; 273:15257-15262.
11. Sogawa K, Numayama-Tsuruta K, Ema M, Abe M, Abe H, Fujii-Kuriyama Y: Inhibition of hypoxia-inducible factor I activity by nitric oxide donors in hypoxia. Proc Natl Acad Sci USA 1998;95:7368-7373.
12. Palmer LA, Gaston B, Johns RA: Normoxic stabilization of hypoxia-inducible factor-1 expression and activity: redox-dependent effect of nitrogen oxides. Mol Pharmacol 2000;58:1197-1203.
13. Kimura H, Weisz A, Kurashima Y, Hashimoto K, Ogura T, D'Acquisto F, Addeo R, Makuuchi M, Esumi H: Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide. Blood 2000;95:189-197.
14. Taira Y, Marsala M: Effects of proximal arterial perfusion pressure on function, spinal cord blood flow, and histopathologic changes after increasing intervals of aortic occlusion in the rat. Stroke 1996;27:1850-1858.
15. Tarlov IM: Spinal Cord Compression: Mechanisms of Paralysis and Treatment. Springfield, Charles C Thomas, 1957, p 147.
16. Herold JA, Kron IL, Langenburg SE, et al: Complete prevention of postischemic spinal cord injury by means of regional infusion with hypothermic saline and adenosine. J Thorac Cardiovasc Surg 1994;107:536-541.
17. Yoshida S, Busto R, Watson BD, Santiso M, Ginsberg MD: Postischemic cerebral lipid peroxidation in vitro: modification by dietary vitamin E. J Neurochem 1985;44:1593-1601.
18. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265-275.
19. Hochachka PW, Buck LT, Doll CJ, Land SC: Unifying theory of hypoxia tolerance: molecular/metabolic defense and rescue mechanisms for surviving oxygen lack. Proc Natl Acad Sci USA 1996;93:9493-9498.
20. Mazure NM, Brahimi-Horn MC, Berta MA, Benizri E, Bilton RL, Dayan F, Ginouves A, Berra E, Pouyssegur J: HIF-1: master and commander of the hypoxic world. A pharmacological approach to its regulation by siRNAs. Biochem Pharmacol 2004;68:971-980.
21. Semenza GL: Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003;3:721-732.
22. 2 tension. Proc Natl Acad Sci USA 1995; 92:5510-5514.
23. 2 homeostasis, Curr Opin Genet Dev 1998;8:588-594.
24. Gleadle JM, Ratcliffe PJ: Hypoxia and the regulation of gene expression. Mol Med Today 1998;4:122-129.
25. Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R, Maxwell P, Koch CJ, Ratcliffe P, Moons L, Jain RK, Collen D, Keshert E, Keshet E: Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 1998;394:485-490.
26. Royer C, Lachuer J, Crouzoulon G, Roux J, Peyronnet J, Mamet J, Pequignot J, Dalmaz Y: Effects of gestational hypoxia on mRNA levels of Glut3 and Glut4 transporters, hypoxia inducible factor-1 and thyroid hormone receptors in developing rat brain. Brain Res 2000; 856:119-128.
27. Semenza GL: HIF-1 and mechanisms of hypoxia sensing. Curr Opin Cell Biol 2001;13:167-171.
28. Denninger JW, Marietta MA: Guanylate cyclase and the NO/cGMP signaling pathway. Biochim Biophys Acta 1999;1411:334-350.
29. Ignarro LJ, Cirino G, Casini A, Napoli C: Nitric oxide as a signaling molecule in the vascular system: an overview. J Cardiovasc Pharmacol 1999;34:879-886.
30. Kasuno K, Takabuchi S, Fukuda K, Kizaka-Kondoh S, Yodoi J, Adachi T, Semenza GL, Hirota K: Nitric oxide induces hypoxia-inducible factor 1 activation that is dependent on MAPK and phosphatidylinositol 3-kinase signaling. J Biol Chem 2004;279:2550-2558.
31. Wang F, Sekine H, Kikuchi Y, Takasaki C, Miura C, Heiwa O, Shuin T, Fujii-Kuriyama Y, Sogawa K: HIF-1 alpha-prolyl hydroxylase: molecular target of nitric oxide in the hypoxic signal transduction pathway. Biochem Biophys Res Commun 2002;295:657-662.
32. Kimura H, Ogura T, Kurashima Y, Weisz A, Esumi H: Effects of nitric oxide donors on vascular endothelial growth factor gene induction. Biochem Biophys Res Commun 2002;296:976-982.
33. Cleeter MW, Cooper JM, Darley-Usmar VM, Moncada S, Schapira AH: Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett 1994;345:50-54.
34. Brown GC, Cooper CE: Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase. FEBS Lett 1994;356:295-298.
35. Brown GC: Nitric oxide and mitochondrial respiration. Biochim Biophys Acta 1999;1411: 351-369.
36. Clementi E, Brown GC, Foxwell N, Moncada S: On the mechanism by which vascular endothelial cells regulate their oxygen consumption. Proc Natl Acad Sci USA 1999;96:1559-1562.
37. Chandel NS, Maltepe E, Goldwasser E, Mathieu CE, Simon MC, Schumacker PT: Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Acad Sci USA 1998;95:11715-11720.
38. Duranteau J, Chandel NS, Kulisz A, Shao Z, Schumacker PT: Intracellular signaling by reactive oxygen species during hypoxia in cardiomyocytes. J Biol Chem 1998;273:11619-11624.
39. 2 sensing. J Biol Chem 2000; 275:25130-25138.
40. Schroedl C, McClintock DS, Scott-Budinger GR, Chandel NS: Hypoxic but not anoxic stabilization of HIF-1alpha requires mitochondrial reactive oxygen species. Am J Physiol Lung Cell Mol Physiol 2002;283:L922-L931.
41. Garcia JJ, Reiter RJ, Guerrero JM, Escames G, Yu BP, Oh CS, Munoz-Hoyos A: Melatonin prevents changes in microsomal membrane fluidity during induced lipid peroxidation. FEBS Lett 1997;408:297-300.
42. Trimarchi H, Mongitore MR, Baglione P, Forrester M, Freixas EAR, Schropp M, Pereyra H, Alonso M: N-acetylcysteine reduces malondialdehyde levels in chronic hemodialysis patients - A pilot study. Clin Nephrol 2003;59:441-446.
43. Freudenthaler SM, Schreeb KH, Wiese A, Pilz J, Gleiter CH: Influence of controlled hypoxia and radical scavenging agents on erythropoietin and malondialdehyde concentration in humans. Acta Physiol Scand 2002;174:231-235.